The Analysis presents the study of Global Diabetic Nephropathy Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold.
Pune, India -- (SBWIRE) -- 03/28/2018 -- MarketResearchFuture.com published a Half-Cooked research report on "Global Diabetic Nephropathy Market Research Report - Forecast to 2023" reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.
You can get easy access to samples from the report here: https://www.marketresearchfuture.com/sample_request/5664 .
Global diabetic nephropathy market is expected to grow at a CAGR of 5.2% during the forecast period.
The report titled "Diabetic Nephropathy Market -Forecast to 2023? is a direct appreciation by Market Research Future of the market potential of the Diabetic Nephropathy Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today's winner takes all market!
Synopsis of the Global Diabetic Nephropathy Market:
Diabetic nephropathy, also known as diabetic kidney disease, is a kidney-related disease to type 1 and type 2 diabetes. This condition affects the normal functioning of the kidney and disturbs its ability to remove waste products and extra fluid from the body. Diabetes and high blood pressure are the major risk factors for diabetic nephropathy. Preventive care includes following a healthy lifestyle and proper monitoring and treatment of high blood pressure and diabetes. Early diagnosis and treatment help to reduce further damage to the kidney, thereby helping in disease management. If left untreated, it may lead to kidney failure, a severe and life-threatening condition.
Factors driving the growth of the market are rising prevalence of chronic diseases diabetes, obesity and increasing demand for diagnostic tests such as urine test, blood test, kidney biopsy, and imaging tests such as MRI and CT scan. As per the data by World Health Organization (WHO), chronic diseases account for nearly 59% of the mortality and death toll due to chronic disease is as high as 35 million across the globe. Furthermore, technological advancements in diagnostic imaging and increasing focus on early diagnosis of diseases also influence the market growth. The accuracy of a diagnostic test for the diagnosis of diabetic nephropathy and the high cost of imaging devices restrain the market growth. Significant growth of medical device industry and availability of cutting-edge technologies for diagnosis further stimulates the market growth.
Key Players in the Global Diabetic Nephropathy Market:
Some of the key players in this market are Merck & Co., Inc. (U.S.), Bayer AG (Germany), Abbott (U.S.), Sanofi (France), Novartis AG (Switzerland), Reata Pharmaceuticals, Inc. (U.S.), Pfizer Inc. (U.S.), AbbVie Inc. (U.S.), Eli Lilly and Company (U.S.), General Electric Company (U.S.), Siemens AG (Germany), Mitsubishi Tanabe Pharma Corporation (Japan) and others.
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation
Access Complete Report Here: https://www.marketresearchfuture.com/reports/diabetic-nephropathy-market-5664 .
The global diabetic nephropathy market is segmented on the basis of diagnosis, treatment, indication, and end user.
On the basis of diagnosis, the market is segmented into blood test, urine tests, imaging tests, renal function testing and kidney biopsy.
Imaging tests are further segmented into X-ray, CT, and MRI.
On the basis of treatment, the market is segmented into medications, kidney dialysis, and transplant.
Medications are further segmented into angiotensin-converting enzyme inhibitors angiotensin II receptor blockers, antioxidant inflammation modulator, renin inhibitors, diuretics, calcium channel blockers, g protein-coupled receptors, connective tissue growth factor inhibitors, monocyte chemoattractant proteins inhibitor, and endothelin-A receptor antagonist.
On the basis of indication, the market is segmented into Diabetes 1 and Diabetes 2.
On the basis of the end user, the market is segmented into hospital & clinics, diagnostic center, research institutes, and others.
Regional Analysis of the Global Diabetic Nephropathy Market:
America diabetic nephropathy is the largest across the globe and is driven by the extensive use of diagnostic tests, rising emphasis on diagnosis and continuous monitoring of diabetes and high blood pressure. Additionally, the prevalence of various kidney diseases is found to be increasing in the U.S. National Chronic Kidney Disease stated that Chronic Kidney Disease (CKD) is common among adults in the U.S. and 30 million people, or 15% of U.S. adults are expected to have chronic kidney disease.
Europe Diabetic Nephropathy market is driven by increasing demand for diagnostics services and growing emphasis on home diagnosis, especially for the geriatric population, with Germany being the largest market. Additionally, the emergence of new market players in medical devices market, thereby increasing competition also boost the market growth. Furthermore, a significant rise in investment for the development of new technologies for the treatment of diseases and favorable reimbursement policies will fuel the market growth during the forecast period.
In Asia Pacific, an alarming increase in the prevalence of chronic disease such as cardiovascular diseases, kidney disease, obesity, diabetes, especially among the geriatric population is a major factor driving the market growth. China and India have the largest diabetic population which is expected to increase drastically in the near future, thereby accelerating the market growth. In India, there is a need to create awareness about diabetes and kidney disease and its diagnosis among the patients. Furthermore, lifestyle changes, sedentary lifestyle, and obesity also contribute to the rise in the prevalence of diabetes and cardiovascular disease.
The market in Middle East & Africa demonstrates steady progress with rising number of diagnostic services, and growing emphasis on diagnosis and treatment of kidney disease. Major economies contributing to the market growth are Saudi Arabia and Unites Arab Emirates (UAE), due to the availability of specialty healthcare services and rising usage of diagnostic devices.
Major TOC of Global Diabetic Nephropathy Market:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Diabetic Nephropathy Market, By Diagnosis
Chapter 7. Global Diabetic Nephropathy Market, By Treatment
Chapter 8. Global Diabetic Nephropathy Market, By Indication
Chapter 9. Global Diabetic Nephropathy Market, By End User
Chapter 10. Global Diabetic Nephropathy Market, By Region
Chapter 11. Company Landscape
Chapter 12. Company Profiles
Chapter 13. MRFR Conclusion
Chapter 14. Appendix
…CONTINUED FOR TOC
Any query or specific requirement? Ask to our industry expert: https://www.marketresearchfuture.com/check-discount/5664 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312